Core Laboratories Income Statement (2022-2026) | CLB

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 120.90M125.97M127.57M128.36M127.88M125.34M128.21M129.64M130.58M134.40M129.24M123.58M130.16M134.52M138.25M121.80M
Cost of Revenue (Quarter) 68.17M67.62M30.16M30.59M29.17M68.98M-93.21M30.72M74.82M75.50M73.13M72.98M74.05M30.00M-106.55M76.11M
Gross Profit (Quarter) 52.73M58.35M97.41M97.76M98.71M56.37M221.42M98.91M55.75M58.89M56.10M50.60M56.11M104.52M244.80M45.68M
Operating items
Amortization - Intangibles (Quarter) 0.17M0.17M0.17M0.10M0.13M0.13M0.13M0.13M0.13M0.12M0.12M0.12M0.11M0.07M0.06M0.21M
Selling, General & Administrative (Quarter) 11.79M10.26M8.64M9.08M13.65M10.46M10.69M10.63M14.72M
Other Operating Expenses (Quarter) -0.08M1.78M0.66M0.03M1.07M-0.67M0.43M-0.85M2.39M4.53M3.88M-2.33M2.97M5.59M1.39M0.65M
Operating Expenses (Quarter) 11.79M10.26M8.64M9.08M13.65M10.46M10.69M10.63M14.72M
Operating Income (Quarter) 11.65M14.64M15.62M6.48M18.91M14.67M14.58M8.57M16.01M19.80M14.17M4.42M15.29M20.93M15.83M1.89M
EBIT (Quarter) 11.65M14.64M15.62M6.48M18.91M14.67M14.58M8.57M16.01M19.80M14.17M4.42M15.29M20.93M15.83M1.89M
Net income details
EBT (Quarter) 8.95M11.51M12.54M3.10M15.67M11.53M10.96M5.10M12.80M16.70M11.54M1.81M12.58M18.28M13.22M-1.00M
Tax Provisions (Quarter) 1.79M3.86M2.97M0.60M-7.26M2.30M19.55M1.70M3.60M4.69M-0.45M1.75M1.91M3.80M8.09M-0.25M
Profit After Tax (Quarter) 7.07M7.52M6.49M2.37M22.93M9.22M2.08M3.49M9.19M11.74M8.16M0.07M10.64M14.24M5.67M-0.75M
Income from Non-Controlling Interests (Quarter) 0.09M0.13M-0.06M0.07M0.08M-0.04M0.48M0.27M0.16M0.26M-0.49M0.22M0.03M0.28M-2.84M0.04M
Income from Continuing Operations (Quarter) 7.16M7.65M9.57M2.50M22.93M9.22M-8.58M3.40M9.20M12.00M11.99M0.07M10.67M14.48M5.13M-0.75M
Consolidated Net Income (Quarter) 7.16M7.65M9.57M2.50M22.93M9.22M-8.58M3.40M9.20M12.00M11.99M0.07M10.67M14.48M5.13M-0.75M
Income towards Parent Company (Quarter) 7.16M7.65M9.57M2.50M22.93M9.22M-8.58M3.40M9.20M12.00M11.99M0.07M10.67M14.48M5.13M-0.75M
Net Income towards Common Stockholders (Quarter) 7.16M7.65M9.57M2.50M22.93M9.22M-8.58M3.40M9.20M12.00M11.99M0.07M10.67M14.48M5.13M-0.75M
Additional items
EPS (Basic) (Quarter) 0.150.170.210.050.490.20-0.180.070.200.260.260.000.230.310.11-0.02
EPS (Diluted) (Quarter) 0.150.160.200.050.480.19-0.180.070.190.250.250.000.230.310.11-0.02
Shares Outstanding (Quarter) 46.32M46.34M46.33M46.63M46.67M46.69M46.68M46.86M46.91M46.92M46.90M46.77M46.63M46.26M46.43M46.07M
Shares Outstanding (Diluted) (Quarter) 47.14M47.01M46.81M47.48M47.50M47.60M47.52M47.70M47.74M47.82M47.69M46.77M47.36M47.08M47.03M46.07M
Shares Outstanding (Entity) (Quarter) 46.32M46.34M46.70M46.63M46.70M46.70M46.94M46.94M46.94M46.94M46.97M46.97M46.97M46.97M46.97M46.97M
EBITDA (Quarter) 11.65M14.64M15.62M6.48M18.91M14.67M14.58M8.57M16.01M19.80M14.17M4.42M15.29M20.93M15.83M1.89M
Interest Expenses (Quarter) 4.35M3.79M8.11M4.17M4.22M3.96M3.83M3.85M7.31M3.88M6.97M4.21M67.70M7.90M9.04M66.14M
Tax Rate (Quarter) 20.00%33.51%23.67%19.35%-46.32%19.96%178.30%33.33%28.13%28.10%-3.87%96.20%15.19%20.79%61.21%25.00%